EPIDEMIOLOGIC STUDIES OF HUMAN RETROVIRUSES IN BLOOD DON

血液中人类逆转录病毒的流行病学研究

• 批准号: 2313327
• 负责人: ALAN E WILLIAMS
• 金额: $ 68.53万
• 依托单位: AMERICAN NATIONAL RED CROSS
• 依托单位国家: 美国
• 财政年份: 1989
• 资助国家: 美国
• 起止时间: 1989-07-17 至 1995-07-16
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/2313327
• 关键词: EPIDEMIOLOGIC; STUDIES; HUMAN; RETROVIRUSES; BLOOD

The objectives of this contract are as follows: 1) determine the prevalence of retrovirus seropositivity in first time blood donors; 20 determine the rate of retrovirus seroconversion in repeat blood donors as a measure of incidence of infection; 3) ascertain risk factors for antibody-positive donors; 4) characterize the blood donor population by geographic location, age, sex, race/ethnicity, and donation history to permit analysis of prevalence, incidence, and risk factors; 5) identify recipients of retrovirus-positive blood units and conduct clinical and laboratory follow-up of these recipients to determine the transmissibility of these agents via transfusion; and 6) establish blood specimen repositories for long-term storage of specimens from study donors and recipients for future testing.

本合同的目标如下： 1) 确定 首次献血者逆转录病毒血清阳性的患病率； 20 确定重复献血者的逆转录病毒血清转化率 作为感染发生率的衡量标准； 3) 确定风险因素 抗体阳性捐献者； 4) 描述献血者群体的特征 地理位置、年龄、性别、种族/民族以及捐赠历史 允许分析患病率、发病率和危险因素； 5）识别 逆转录病毒阳性血液单位的接受者并进行临床和 对这些接受者进行实验室随访以确定 这些药物可通过输血传播； 6）建立血液 用于长期储存研究样本的样本库 捐赠者和接受者进行未来的测试。